Chinese earnings returned to growth in the third quarter but a closer look at the numbers reveals a picture that’s far less ...

An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...

AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...

Shares are mixed in Asia after U.S. stock indexes drifted lower at the start of a momentous week full of potential ...

Investors are waiting anxiously to see details of a fiscal stimulus package expected to be confirmed by Chinese authorities ...

The comparatively lower valuations of China’s market, combined with stimulus measures aimed at bolstering Asia’s largest ...

Shares are mostly higher in Asia as China's leaders begin a major meeting expected to bring fresh pledges of help for the ...

Li Auto stock remains down by about 28% year-to-date. There have been a couple of headwinds for Li Auto. Competition in the Chinese EV market is intense, hurting the company’s average selling prices ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker.

China's lawmakers propose $1.4 trillion stimulus to revive economy and address local debt. Chinese stocks and EVs gain momentum.

ASM International (ASMIY) reported strong 3Q24 results, driven by robust demand for GAA and HBM technologies. Read why I ...

Chinese shares rallied after a private gauge of China's services sector showed a strong October reading, adding to recent signs that Beijing's stimulus push is revitalizing the world's second-largest ...